Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

NCT01523236 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Mometasone furoate
DRUG: Nasonex®
DRUG: Placebo

Sponsor

Teva Pharmaceuticals USA